| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 6.2e-05 | 1 |